Estimating the activity of transcription factors by the effect on their target genes

Motivation: Understanding regulation of transcription is central for elucidating cellular regulation. Several statistical and mechanistic models have come up the last couple of years explaining gene transcription levels using information of potential transcriptional regulators as transcription factors (TFs) and information from epigenetic modifications. The activity of TFs is often inferred by their transcription levels, promoter binding and epigenetic effects. However, in principle, these methods do not take hard-to-measure influences such as post-transcriptional modifications into account. Results: For TFs, we present a novel concept circumventing this problem. We estimate the regulatory activity of TFs using their cumulative effects on their target genes. We established our model using expression data of 59 cell lines from the National Cancer Institute. The trained model was applied to an independent expression dataset of melanoma cells yielding excellent expression predictions and elucidated regulation of melanogenesis. Availability and implementation: Using mixed-integer linear programming, we implemented a switch-like optimization enabling a constrained but optimal selection of TFs and optimal model selection estimating their effects. The method is generic and can also be applied to further regulators of transcription. Contact: rainer.koenig@uni-jena.de Supplementary information: Supplementary data are available at Bioinformatics online.

[1]  Raymond K. Auerbach,et al.  An Integrated Encyclopedia of DNA Elements in the Human Genome , 2012, Nature.

[2]  E. Segal,et al.  Predicting expression patterns from regulatory sequence in Drosophila segmentation , 2008, Nature.

[3]  J. Weinstein,et al.  mRNA and microRNA Expression Profiles of the NCI-60 Integrated with Drug Activities , 2010, Molecular Cancer Therapeutics.

[4]  G. Rousseau,et al.  The transcription factor onecut-2 controls the microphthalmia-associated transcription factor gene. , 2001, Biochemical and biophysical research communications.

[5]  Andrea Califano,et al.  hARACNe: improving the accuracy of regulatory model reverse engineering via higher-order data processing inequality tests , 2013, Interface Focus.

[6]  R. Shoemaker The NCI60 human tumour cell line anticancer drug screen , 2006, Nature Reviews Cancer.

[7]  Data production leads,et al.  An integrated encyclopedia of DNA elements in the human genome , 2012 .

[8]  R. Sturm,et al.  POU domain transcription factors: BRN2 as a regulator of melanocytic growth and tumourigenesis , 2008, Pigment cell & melanoma research.

[9]  Tijana Milenkovic,et al.  Protein interaction network topology uncovers melanogenesis regulatory network components within functional genomics datasets , 2010, BMC Systems Biology.

[10]  Manu Setty,et al.  Inferring transcriptional and microRNA-mediated regulatory programs in glioblastoma , 2012, Molecular systems biology.

[11]  J. Collins,et al.  Large-Scale Mapping and Validation of Escherichia coli Transcriptional Regulation from a Compendium of Expression Profiles , 2007, PLoS biology.

[12]  R. Sharan,et al.  A systems-level approach to mapping the telomere length maintenance gene circuitry , 2008, Molecular systems biology.

[13]  I. Rebay,et al.  Post‐translational modifications influence transcription factor activity: A view from the ETS superfamily , 2005, BioEssays : news and reviews in molecular, cellular and developmental biology.

[14]  D. Fell,et al.  Detection of elementary flux modes in biochemical networks: a promising tool for pathway analysis and metabolic engineering. , 1999, Trends in biotechnology.

[15]  Chris Wiggins,et al.  ARACNE: An Algorithm for the Reconstruction of Gene Regulatory Networks in a Mammalian Cellular Context , 2004, BMC Bioinformatics.

[16]  Rachel E. Kerwin,et al.  Network Quantitative Trait Loci Mapping of Circadian Clock Outputs Identifies Metabolic Pathway-to-Clock Linkages in Arabidopsis[C][W] , 2011, Plant Cell.

[17]  K. Kohn,et al.  CellMiner: a web-based suite of genomic and pharmacologic tools to explore transcript and drug patterns in the NCI-60 cell line set. , 2012, Cancer research.

[18]  Roland Eils,et al.  Enhancers regulate progression of development in mammalian cells , 2011, Nucleic acids research.

[19]  D. Schadendorf,et al.  Metastatic potential of melanomas defined by specific gene expression profiles with no BRAF signature. , 2006, Pigment cell research.

[20]  Kevin Y. Yip,et al.  Understanding transcriptional regulation by integrative analysis of transcription factor binding data , 2012, Genome research.

[21]  W. Pavan,et al.  Sox proteins in melanocyte development and melanoma , 2010, Pigment cell & melanoma research.

[22]  M. Ivan,et al.  Structure of an HIF-1α-pVHL Complex: Hydroxyproline Recognition in Signaling , 2002, Science.

[23]  Avi Ma'ayan,et al.  ChEA: transcription factor regulation inferred from integrating genome-wide ChIP-X experiments , 2010, Bioinform..

[24]  Helen Pickersgill,et al.  Oncogenic BRAF Regulates Melanoma Proliferation through the Lineage Specific Factor MITF , 2008, PloS one.

[25]  T. Filtz,et al.  Regulation of transcription factor activity by interconnected post-translational modifications. , 2014, Trends in pharmacological sciences.

[26]  ENCODEConsortium,et al.  An Integrated Encyclopedia of DNA Elements in the Human Genome , 2012, Nature.

[27]  D. Fisher,et al.  MITF: master regulator of melanocyte development and melanoma oncogene. , 2006, Trends in molecular medicine.

[28]  Gerhard Reinelt,et al.  PathWave: discovering patterns of differentially regulated enzymes in metabolic pathways , 2010, Bioinform..

[29]  Ivan Molineris,et al.  Evolution of promoter affinity for transcription factors in the human lineage. , 2011, Molecular biology and evolution.

[30]  James B. Brown,et al.  Modeling gene expression using chromatin features in various cellular contexts , 2012, Genome Biology.

[31]  Mudita Singhal,et al.  Network Inference Algorithms Elucidate Nrf2 Regulation of Mouse Lung Oxidative Stress , 2008, PLoS Comput. Biol..

[32]  Te-Sheng Chang,et al.  An Updated Review of Tyrosinase Inhibitors , 2009, International journal of molecular sciences.

[33]  B O Palsson,et al.  Optimal selection of metabolic fluxes for in vivo measurement. I. Development of mathematical methods. , 1992, Journal of theoretical biology.